Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carlos A. Encarnacion
Observed names:
C Encarnacion,
C. Encarnacion,
Carlos A Encarnación,
Carlos Encarnacion
Institution:
Texas Oncology
Observed institutions:
McKesson (United States),
The University of Texas at San Antonio Health Science Center,
Texas Oncology,
The US Oncology Network,
Pontifícia Universidade Católica do Rio Grande do Sul,
Saint Louis University
show all 6
OpenAlex ID:
A5038347252
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2017
·
Miguel Martin
, Frankie A Holmes
, et al.
·
The Lancet Oncology
·
647
Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
2009
·
Michael G. Teneriello
, Paul C. Tseng
, et al.
·
Journal of Clinical Oncology
·
85
PDF
Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer
2005
·
Thomas Cartwright
, Timothy Lopez
, et al.
·
Clinical Colorectal Cancer
·
37
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
2019
·
Sneha Berry
, Nicolas Giraldo
, et al.
·
Journal for ImmunoTherapy of Cancer
·
26
PDF
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer
2009
·
John W. Smith
, Kristi J. McIntyre
, et al.
·
Breast Cancer Research and Treatment
·
17
A phase Ib/II trial of lenvatinib plus pembrolizumab in non-small cell lung cancer.
2019
·
Marcia S. Brose
, Nicholas J. Vogelzang
, et al.
·
Journal of Clinical Oncology
·
15
Estrogen receptor variants in breast cancer
1994
·
Carlos A. Encarnacion
, Suzanne A. W. Fuqua
·
Cancer treatment and research
·
13
Phase Ib/II trial of lenvatinib plus pembrolizumab in urothelial cancer.
2019
·
Nicholas J. Vogelzang
, Carlos A. Encarnacion
, et al.
·
Journal of Clinical Oncology
·
9
A Phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer
2004
·
T. H. Cartwright
, T. Lopez
, et al.
·
Journal of Clinical Oncology
·
8
Durable complete remission in a patient with refractory mediastinal non-seminomatous germ cell tumor after tandem high-dose chemotherapy and autologous bone marrow transplantation.
1993
·
D Adkins
, C Encarnacion
, et al.
·
PubMed
·
7
Results of a phase II evaluation of nanoparticle albumin bound paclitaxel (nab-paclitaxel) in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer
2007
·
M. G. Teneriello
, P. C. Tseng
, et al.
·
Journal of Clinical Oncology
·
5
Molecular profiles of genomically high risk ER+ HER2- breast cancer tumors classified as functionally basal or luminal B by the 80-gene signature.
2021
·
Joyce O'Shaughnessy
, Virginia G. Kaklamani
, et al.
·
Journal of Clinical Oncology
·
3
Estrogen Receptor Variants in Breast Cancer
1994
·
Carlos A. Encarnacion
, Suzanne A. W. Fuqua
·
Birkhäuser Boston eBooks
·
3
Atrial Fibrillation Ablation-induced Pulmonary Venous Occlusion Requiring Pneumonectomy
2022
·
Rajesh Venkataraman
, Pranav Loyalka
, et al.
·
The Annals of Thoracic Surgery
·
1
PDF
High-risk breast cancer genes at 8q22-24 and their role in over 5,000 patients evaluated with the 70-gene risk of recurrence assay.
2020
·
Sami Diab
, Matei P. Socoteanu
, et al.
·
Journal of Clinical Oncology
·
1
The Breast Cancer Index Registry Study: Initial analysis of the first 1,000 patients.
2022
·
Joyce O'Shaughnessy
, Carlos A. Encarnacion
, et al.
·
Journal of Clinical Oncology
Abstract OT1-10-01: The Breast Cancer Index registry study: A prospective multi-center observational study to evaluate patient outcome, clinical impact, and medication adherence in HR+ breast cancer patients considering treatment with extended endocrine therapy
2022
·
Joyce A O'Shaughnessy
, Jenny R Fox
, et al.
·
Cancer Research
Cancer Genetics and Risk Assessment: The Practicing Clinician’s Role
2014
·
Carlos Encarnacion
·
Journal of Cancer Prevention & Current Research
PDF
Show more works
View as search
Works count:
18
Citation count:
877
H-index:
8
I10-index:
7
Year
Topic
Type